Cancer Therapy
ArQule provides clinical trial update on cancer drug candidates
Published in Cancer Weekly, February 13th, 2007
"Progress is continuing toward proof-of-principle with our clinical-stage products," said Stephen A. Hill, president and chief executive officer of ArQule. "Patients have been recruited in a timely fashion, and we expect to begin presenting data from these trials by the middle of this year."
The company has completed dose escalation in its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-02-13)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Data from Johns Hopkins Medical Institutions, Department of Pathology advance knowledge in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Hokkaido University - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at University of Maryland, Department of Radiation Oncology - Cancer Gene Therapy
Data on cancer gene therapy published by researchers at University of Brescia - Cancer Gene Therapy
Data on cancer gene therapy published by researchers at University of Helsinki, Haartman Institute - Cancer Gene Therapy
Investigators at Queen Mary Hospital zero in on cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
